אולנזפין טבע ® 15 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

OLANZAPINE 15 MG

Verfügbar ab:

SALOMON,LEVIN & ELSTEIN LTD

ATC-Code:

N05AH03

Darreichungsform:

FILM COATED TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Therapiegruppe:

OLANZAPINE

Anwendungsgebiete:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Berechtigungsdatum:

2011-04-01